BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bi MR, Zhu LY, Yan BZ, Chen LY, Wang FX, Ma YJ, Yang BS. Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression. Hepat Mon 2014;14:e23552. [PMID: 25685165 DOI: 10.5812/hepatmon.23552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Xiang L, Li H, Chen P, Feng Y, Zhang J, Yang N, Li F, Wang Y, Zhang Q. The role of HMGB1 signaling pathway in the development and progression of hepatocellular carcinoma: a review. Int J Mol Sci. 2015;16:22527-22540. [PMID: 26393575 DOI: 10.3390/ijms160922527] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
2 Wang B, Yeh CB, Lein MY, Su CM, Yang SF, Liu YF, Tang CH. Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma. Int J Med Sci. 2016;13:304-309. [PMID: 27076788 DOI: 10.7150/ijms.14877] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang W, An F, Xia M, Zhan Q, Tian W, Jiao Y. Increased HMGB1 expression correlates with higher expression of c-IAP2 and pERK in colorectal cancer. Medicine (Baltimore) 2019;98:e14069. [PMID: 30653121 DOI: 10.1097/MD.0000000000014069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]